Evaluation of a New Tranquillizer—WY 4036—in the Treatment of Anxiety
- 1 December 1971
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 119 (553) , 597-598
- https://doi.org/10.1192/bjp.119.553.597
Abstract
Fifty patients (30 females and 20 males) suffering from a neurotic anxiety illness or from anxiety associated with depression were treated with WY 4036 or placebo in a double-blind controlled trial. The treatment lasted for three weeks. Patients were assessed before the start of the trial at intervals of one week, two weeks and three weeks. After the fourth and final assessment a four-point global assessment was also made and interpreted as `greatly improved', improved', 'no change', or `worse'.Keywords
This publication has 1 reference indexed in Scilit:
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959